AMY CLEVENGER: Open Payments
NPI 1609515972 · ELKINS, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,728 in 134 payments from 17 companies in 2025. Trend: 2023 $20 · 2024 $3,026 · 2025 $2,728
Food & beverage: $2,493Education: $235
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $557 |
| JAZZ PHARMACEUTICALS INC. | 22 | $419 |
| GlaxoSmithKline, LLC. | 23 | $407 |
| HARMONY BIOSCIENCES LLC | 13 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $222 |
| Verona Pharma, Inc. | 8 | $194 |
| Regeneron Healthcare Solutions, Inc. | 7 | $139 |
| Insmed, Inc. | 6 | $101 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Vifor Pharma, Inc. | 4 | $85 |
Products named: FASENRA, NUCALA, Ohtuvayre, DUPIXENT, BREZTRI, WAKIX, XYWAV, Sunosi.
Industry payments across WV — which companies pay providers there.
